Results 251 to 260 of about 1,967,755 (312)

Measurement, spatiotemporal evolution, and obstacle factor diagnosis of new quality productive forces in China's leading TCM manufacturing enterprises. [PDF]

Cost Eff Resour Alloc
Zhiguang L, Yu Y, Jingyu S, Yushan C, Ruijin X.   +4 more
europepmc   +1 more source

The impact of fine particulate pollution (PM2.5) on hospitalization costs in China. [PDF]

Front Public Health
Chen C, Ma C, Wu X, Song J, Yan J.
europepmc   +1 more source

Pharmacoeconomic evaluation of weight-based vs fixed-dose pembrolizumab for non-small cell lung cancer in China. [PDF]

Front Immunol
Wu M, Yi Y, Li A, Meng K, Zhang Z, Shi C, Tan C, Wan X, Ma J.   +8 more
europepmc   +1 more source

An Introduction to Costing and the Types of Costs Used within Health Economic Studies. [PDF]

Pharmacoecon Open
Turner HC, Rivillas-Garcia JC, Prinja S, Hung TM, Dabak SV, Asare BA, Jit M, Teerawattananon Y.   +7 more
europepmc   +1 more source

Multidimensional impact of fixed-dose subcutaneous trastuzumab-pertuzumab on oncology workflow and patient time burden in a real-world study. [PDF]

Breast Cancer
Oshi M, Nakayama T, Ota I, Sasamoto M, Yamada A, Narui K, Takabe K, Endo I.   +7 more
europepmc   +1 more source